Cargando…

P55 MULTIPLE MYELOMA AND SARS-COV-2 INFECTION: AN EUROPEAN HEMATOLOGY ASSOCIATION SURVEY (EPICOVIDEHA) OF 1,221 PATIENTS THROUGH THE DIFFERENT PHASES OF COVID-19 PANDEMIC

Detalles Bibliográficos
Autores principales:	Musto, P., Salmanton-García, J., Sgherza, N., Bergantim, R., Farina, F., Glenthøj, A., Seval, G.C., Weinbergerová, B., Bonuomo, V., Bilgin, Y.M., Rahimli, L., Marchesi, F., Cornely, O.A., Pagano, L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Poster
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171490/ http://dx.doi.org/10.1097/01.HS9.0000936348.78046.5c

Ejemplares similares

P1514: MOLNUPIRAVIR COMPARED TO NIRMATRELVIR/RITONAVIR FOR COVID-19 IN HIGH-RISK PATIENTS WITH HAEMATOLOGICAL MALIGNANCY IN EUROPE. A MATCHED-PAIRED ANALYSIS FROM THE EPICOVIDEHA REGISTRY
por: Salmanton-García, Jon, et al.
Publicado: (2023)

Unveiling the Hidden Burden: From EPICOVIDEHA to EPIFLUEHA, Exploring the Epidemiology of Respiratory Viral Infections in Hematological Patients
por: Salmanton-García, Jon, et al.
Publicado: (2023)

EPICOVIDEHA: A Ready to Use Platform for Epidemiological Studies in Hematological Patients With COVID-19
por: Salmanton-García, Jon, et al.
Publicado: (2021)

Simultaneous Onset of Haematological Malignancy and COVID: An Epicovideha Survey
por: Cattaneo, Chiara, et al.
Publicado: (2022)

COVID-19 and hairy-cell leukemia: an EPICOVIDEHA survey
por: Lamure, Sylvain, et al.
Publicado: (2022)

COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA
por: Pagano, Livio, et al.
Publicado: (2022)

P1607: EPICOVIDEHA KIDS: A READY TO USE PLATFORM FOR EPIDEMIOLOGICAL STUDIES IN PEDIATRIC HEMATOLOGICAL PATIENTS WITH COVID-19
por: Salmanton-García, J., et al.
Publicado: (2022)

Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry
por: Busca, Alessandro, et al.
Publicado: (2023)

COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP
por: Busca, Alessandro, et al.
Publicado: (2022)

Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry
por: Marchetti, Monia, et al.
Publicado: (2023)

COVID-19 Infection in Vaccinated Adult Patients with Hematological Malignancies. Preliminary Results from Epicovideha (Epidemiology of COVID-19 infection in patients with hematological malignancies: A European Haematology Association Survey)
por: Marchesi, Francesco, et al.
Publicado: (2021)

Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry
por: Marchesi, Francesco, et al.
Publicado: (2023)

Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine: An EPICOVIDEHA Report
por: Salmanton-García, Jon, et al.
Publicado: (2022)

P1521: IMPROVED CLINICAL OUTCOME OF COVID-19 IN HAEMATOLOGIC MALIGNANCY PATIENTS RECEIVING A FOURTH DOSE OF ANTI-SARS-COV-2 VACCINE: AN EPICOVIDEHA REPORT
por: Salmanton-García, Jon, et al.
Publicado: (2023)

Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry
por: Salmanton-García, Jon, et al.
Publicado: (2023)

Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey
por: Pagano, Livio, et al.
Publicado: (2022)

Outcome of infection with omicron SARS‐CoV‐2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report
por: Blennow, Ola, et al.
Publicado: (2022)

S292: NIRMATRELVIR/RITONAVIR IN COVID-19 PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES: A REPORT FROMTHE EPICOVIDEHA REGISTRY
por: Salmanton-García, Jon, et al.
Publicado: (2023)

B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA)
por: Infante, Maria Stefania, et al.
Publicado: (2022)

COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)
por: Pagano, Livio, et al.
Publicado: (2021)

Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post–CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey
por: van Doesum, Jaap A., et al.
Publicado: (2023)

COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA)
por: Marchesi, Francesco, et al.
Publicado: (2022)

1221. Evaluation of the FilmArray® Global Fever Panel
por: Helm, Jared R, et al.
Publicado: (2020)

GATA2 regulates the erythropoietin receptor in t(12;21) ALL
por: Gaine, Marie E., et al.
Publicado: (2017)

1221 Air and Surface Burden of Measles Virus in a Hospital Setting
por: Stehle, John, et al.
Publicado: (2014)

PB2586: PASSIVE PREEXPOSURE IMMUNIZATION BY TIXAGEVIMAB/CILGAVIMAB IN COVID 19 INFECTED HEMATOLOGICAL MALIGNANCY OF EPICOVIDHEA SURVEY
por: Buquicchio, Caterina, et al.
Publicado: (2023)

Histoire mexicaine depuis 1221 jusqu'en 1594 : Manuscrito núm. 40 del Fondo de Manuscritos Mexicanos, Biblioteca Nacional de Francia /
Publicado: (1998)

Erratum to “The analysis of C9orf72 repeat expansions in a large series of clinically and pathologically diagnosed cases with atypical parkinsonism” [Neurobiol. Aging 36 (2015) 1221.e1–1221.e6]
por: Schottlaender, Lucia V., et al.
Publicado: (2015)

Fluorescence in situ Hybridization Analysis of 12;21 Translocation in Japanese Childhood Acute Lymphoblastic Leukemia
por: Eguchi‐Ishimae, Minenori, et al.
Publicado: (1998)

ARHGEF4 Regulates an Essential Oncogenic Program in t(12;21)-Associated Acute Lymphoblastic Leukemia
por: Virely, Clemence, et al.
Publicado: (2020)

1221. Comparison of the Antimicrobial Efficacy of Mobile Ultraviolet Light Devices in a Simulated Patient Room
por: Boyce, John M, et al.
Publicado: (2019)

The Landscape of Secondary Genetic Rearrangements in Pediatric Patients with B-Cell Acute Lymphoblastic Leukemia with t(12;21)
por: Kaczmarska, Agnieszka, et al.
Publicado: (2023)

1221. Genomic Factors Affecting the Efficacy of Antimicrobial Therapy in Daptomycin-, Linezolid-, Vancomycin-Resistant Enterococcus faecium (DLVRE)
por: Gatesy, Samuel W, et al.
Publicado: (2021)

Run 1217 - 26 GeV/c, Run 1221 - 26 GeV/c, Beam-beam instabilities II
por: CERN. Geneva. Intersecting Storage Ring Division
Publicado: (1982)

From words to pixels: The Infectious Diseases in Motion (IDIM) and VACCELERATE experience for fast and accessible science audiovisual communication
por: Salmanton-García, Jon, et al.
Publicado: (2023)

Run 1221, 26 GeV/c, Ring 1 only, 1st October 1981, Beam Stability during Stacking
por: Dahlerup-Petersen, K
Publicado: (1981)

Monkeypox diagnostic and treatment capacity at epidemic onset: A VACCELERATE online survey
por: Grothe, Jan Hendrik, et al.
Publicado: (2022)

Monkeypox in children and adult women in Europe: Results from a flash VACCELERATE pilot survey
por: Grothe, Jan Hendrik, et al.
Publicado: (2023)

Monkeypox in children and adult women in Europe: Results from a flash VACCELERATE pilot survey
por: Grothe, Jan Hendrik, et al.
Publicado: (2023)

Novel Approaches Outside the Setting of Immunotherapy for the Treatment of Multiple Myeloma: The Case of Melflufen, Venetoclax, and Selinexor
por: Sgherza, Nicola, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r9rl1tinokemmn3mli2moo7vsp